The physicians' health study: aspirin for the primary prevention of myocardial infarction. - Suppr | 超能文献

The physicians' health study: aspirin for the primary prevention of myocardial infarction.

出版信息

N Engl J Med. 1988 Apr 7;318(14):924-6. doi: 10.1056/NEJM198804073181413.

DOI:10.1056/NEJM198804073181413

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The physicians' health study: aspirin for the primary prevention of myocardial infarction.

N Engl J Med. 1988 Apr 7;318(14):924-6. doi: 10.1056/NEJM198804073181413.

2

The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.

JAMA. 1988 Jun 3;259(21):3158-60.

3

An overview of the British and American aspirin studies.英美阿司匹林研究综述。

N Engl J Med. 1988 Apr 7;318(14):923-4. doi: 10.1056/NEJM198804073181412.

4

Regulating information about aspirin and the prevention of heart attack.规范有关阿司匹林与心脏病发作预防的信息。

Am Econ Rev. 1995 May;85(2):96-9.

5

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.心血管药物的随机临床试验结果会影响医学实践吗？心肌梗死存活研究（SAVE）调查组。

N Engl J Med. 1992 Jul 23;327(4):241-7. doi: 10.1056/NEJM199207233270405.

6

Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Asia-Pacific.亚太地区在线问卷调查研究：医生对心梗后阿司匹林预防的态度。

Postgrad Med. 2010 Jan;122(1):108-17. doi: 10.3810/pgm.2010.01.2104.

7

Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.

Am J Prev Med. 1991 May-Jun;7(3):150-4.

8

FDA questions use of aspirin for primary prevention of stroke and heart attack.

BMJ. 2014 May 8;348:g3168. doi: 10.1136/bmj.g3168.

9

[Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].

Ned Tijdschr Geneeskd. 1981 Oct 3;125(40):1606-9.

10

Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.对六项使用阿司匹林进行心血管事件一级预防试验的数据进行的荟萃分析。

Am J Cardiol. 2006 Sep 15;98(6):746-50. doi: 10.1016/j.amjcard.2006.04.012. Epub 2006 Jul 26.

引用本文的文献

1

Sex and the Lab: An Alcohol-Focused Commentary on the NIH Initiative to Balance Sex in Cell and Animal Studies.性别与实验室：关于美国国立卫生研究院在细胞和动物研究中平衡性别比例倡议的酒精相关评论

Alcohol Clin Exp Res. 2016 Jun;40(6):1182-91. doi: 10.1111/acer.13072. Epub 2016 May 7.

2

Clinical use of aspirin in treatment and prevention of cardiovascular disease.阿司匹林在心血管疾病治疗和预防中的临床应用。

Thrombosis. 2012;2012:245037. doi: 10.1155/2012/245037. Epub 2011 Nov 24.

3

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study.罗非昔布在英国全科医疗中的安全性概况：一项处方事件监测研究的结果。

Br J Clin Pharmacol. 2003 Feb;55(2):166-74. doi: 10.1046/j.1365-2125.2003.01763.x.

4

Periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Canadian Task Force on the Periodic Health Examination.定期健康检查，1991年更新版：6. 乙酰水杨酸与心血管疾病的一级预防。加拿大定期健康检查特别工作组。

CMAJ. 1991 Nov 1;145(9):1091-5.